NEW LIPOPHILIC TERBUTALINE ESTER PRODRUGS WITH LONG EFFECT DURATION

被引：61

作者：

OLSSON, OAT ^{[1
]}

SVENSSON, LA ^{[1
]}

机构：

[1] AB DRACO,RES & DEV LABS,POB 1707,S-22101 LUND,SWEDEN

来源：

PHARMACEUTICAL RESEARCH | 1984年 / 01期

关键词：

D O I：

10.1023/A:1016322524471

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

收藏

页码：19 / 23

页数：5

相关论文

共 13 条

[1] METABOLISM OF TERBUTALINE IN MAN AND DOG
DAVIES, DS
GEORGE, CF
BLACKWELL, E
CONOLLY, ME
DOLLERY, CT
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 1 (02) : 129 - 136
[2] GILETTE JR, 1974, PHARM PHARMACOKINETI, P209
[3] METABOLISM AND CLINICAL ACTIVITY OF TERBUTALINE AND ITS PRODRUG IBUTEROL
HORNBLAD, Y
RIPE, E
MAGNUSSON, PO
TEGNER, K
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 10 (01) : 9 - 18
[4] DETERMINATION OF TERBUTALINE IN PLASMA BY GAS-CHROMATOGRAPHY CHEMICAL IONIZATION MASS-SPECTROMETRY
JACOBSSON, SE
JONSSON, S
LINDBERG, C
SVENSSON, LA
[J]. BIOMEDICAL MASS SPECTROMETRY, 1980, 7 (06): : 265 - 268
[5] KRISTOFFERSSON J, 1974, ACTA PHARM SUEC, V11, P427
[6] NILSSON HT, 1972, XENOBIOTICA, V2, P363
[7] OLSSON OAT, 1971, ACTA ALLERGOL, V26, P438
[8] OLSSON OAT, 1981, ACTA PHARMACOL TOX, V48, P340
[9] OLSSON OAT, 1974, ACTA PHARMACOL TOX, V35, P76
[10] OLSSON OAT, 1981, Patent No. 818501181